Simultaneous Determination of Carbamate and Organophosphorus Pesticides in Honeybees by Liquid Chromatography-Mass Spectrometry

Summary The potential of liquid chromatography-mass spectrometry (LC-MS) has been studied for the simultaneous determination of sixteen carbamate and organophosphorus pesticides in honeybees using a traditional sample preparation protocol based on acetone extraction and dichloromethane partitioning. The performances of both atmospheric pressure chemical ionization (APCI) and electrospray (ES) interfaces were compared. APCI offered better sensitivity and specificity for a higher range of pesticides. Limits of quantification were from 0.01 to 0.17 mg kg^–1, at which recoveries obtained were between 64 and 93%, except for pirimicarb that was at 13%, with relative standard deviations ranging from 7 to 20%. Fenitrothion, fenoxycarb, methiocarb and phoxim were found in bees from Valencian Community beehives at concentrations between 0.03 and 3.75 mg kg^–1.     

Kinetics and mechanism of one dipicolinato ligand substitution in the chromium(III)–bis(dipicolinato) complex: an unusual rate dependence on acid concentration

The Na[Cr(PDA)₂] · 2H₂O complex (PDA¹ = dipicolinic acid anion) and its aquation product, [Cr(PDA)(H₂O)₃]⁺, were prepared and characterized. The electronic spectra demonstrate that the bis(dipicolinato) complex undergoes very fast partial dechelation during dissolution. In acidic media, pH controlled, rapid protolytic and ring opening processes lead to coexistence of complexes with one tridentate (PDA) and the other bi- or mono-dentate (PDA). The kinetics of PDA ligand liberation were followed spectrophotometrically within the 0.1–2.0 M HClO₄ range at I = 2.0 M. The observed first-order rate constant depends on [H⁺] according to the equation: k _obs = A[H⁺]/(1 + B[H⁺] + C[H⁺]²). A reaction course via the uncharged [Cr(PDA)(HPDA)(H₂O)₂]⁰ complex is proposed. The observed rate increase, followed by rate retardation with [H⁺] increase, is attributed to the unreactive [Cr(PDA)(H₂PDA)(H₂O)₂]⁺ complex. In terms of the proposed mechanism, A, B, C parameters have been defined as: A = k ₁ Q ₁, B = Q ₁, C = Q ₁ Q ₂ where k ₁ is the rate constant of the Cr^III-carboxylato oxygen bond-breaking in the monodentate HPDA ligand, Q ₁ is a composite value describing protolytic and dechelation processes and Q ₂ is the protonation constant of the uncharged [Cr(PDA)(HPDA)(H₂O)₂]⁰ complex.     

Simultaneous determination of levofloxacin and ciprofloxacin in human urine by ionic‐liquid‐based,dual‐template molecularly imprinted coated graphene oxide monolithic solid‐phase extraction

A novel method was developed to simultaneously determine the ciprofloxacin and levofloxacin levels in human urine using an ionic‐liquid‐based, dual‐molecularly imprinted polymer‐coated graphene oxide solid‐phase extraction monolithic column coupled with high‐performance liquid chromatography. The molecularly imprinted monolithic column was prepared using ciprofloxacin and levofloxacin as templates, 1‐vinyl‐3‐ethylimidazolium bromide as the functional monomer, and graphene oxide as the core material. The resulting imprinted monoliths were characterized by scanning electron microscopy and fourier transform‐infrared spectroscopy. The efficiency and capacity of the ionic‐liquid‐based imprinted monolithic column were investigated by varying the synthesis conditions (ciprofloxacin/levofloxacin ratio and template/functional monomer/cross‐linker ratio). The solid‐phase extraction process was optimized by changing the washing and eluting conditions. The results suggested that the proposed ionic‐liquid‐based molecularly imprinted solid‐phase extraction monolithic‐high‐performance liquid chromatography method could separate ciprofloxacin and levofloxacin efficiently and simultaneously from human urine. The mean recoveries of ciprofloxacin and levofloxacin ranged from 89.2 to 93.8 and 86.7 to 94.6%, respectively. The intra‐ and interday relative standard deviation ranged from 0.9 to 3.2 and 0.8 to 2.9%, respectively. Under the optimized conditions, the recoveries of ciprofloxacin and levofloxacin were more than 93.8%.     

Separation and purification of lanosterol,dihydrolanosterol, and cholesterol from lanolin by high‐performance counter‐current chromatography dual‐mode elution method

Lanosterol is a potential drug for cataracts treatment, which can reverse the aggregation of intracrystalline proteins. The low concentration in lanolin calls for high‐performance separation methods. In this study, a counter‐current chromatography dual‐mode elution method was developed for the first time to separate and purify lanosterol from hexane extract of lanolin after saponification, in which the column was first eluted with the lower phase as mobile phase in head‐to‐tail mode, followed by the upper phase in the tail‐to‐head mode. High purity of lanosterol, dihydrolanosterol, and cholesterol can be obtained simultaneously. A solvent system composed of n‐heptane/acetonitrile/ethyl acetate (5:5:1, v/v/v) was selected and optimized via partition coefficient determination. Compounds such as 111 mg lanosterol, 84 mg dihydrolanosterol, and 183 mg cholesterol with high purity of 99.77, 95.71, and 91.43%, respectively, analyzed by high‐performance liquid chromatography were obtained within 80 min from 700 mg crude extract from 1.78 g lanolin. The method was also used to improve the purity of commercial lanosterol product from 66.97 to above 99%. Counter‐current chromatography could serve as a potential and powerful technique for commercial production of highly pure lanosterol.     

Analysis of sialic acid levels in Chinese intravenous immunoglobulins by high‐performance liquid chromatography with fluorescence detection

Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of autoimmune and systemic inflammatory diseases with both licensed and off‐label indications. Recent studies indicated that IVIg‐mediated immunomodulation and anti‐inflammation are closely associated with the IgG sialylation, especially with IgG crystallizable fragment (Fc) sialylation. The sialic acid levels of the IgG molecules and Fc fragments in 12 IVIg preparations from six Chinese manufacturers were evaluated. The Fc fragments were derived from the papain digestion of IVIg, followed by affinity and size exclusion chromatography. The sialic acid levels in Fc fragments and IVIg preparations were determined by high‐performance liquid chromatography with fluorescence detection, after the sialic acid residues were released from the proteins. The results showed that the sialic acid levels in Chinese IVIg preparations ranged from 0.875 (mol/mol IgG) to 1.085 (mol/mol IgG), and the sialic acid levels in Fc fragments were from 0.321 (mol/mol Fc) to 0.361 (mol/mol Fc). Furthermore, the sialic acid levels of IVIg preparations and Fc fragments from different Chinese manufactures were significantly different. These findings will contribute to an increased understanding of Chinese IVIg preparations and the relationship between the sialic acid levels in IVIg preparations and their clinical efficacy in future clinical studies.     

Metabolomics study on promoting blood circulation and ameliorating blood stasis: Investigating the mechanism of Angelica sinensis and its processed products

Angelica sinensis (Danggui, DG) parched with alcohol (Jiu Danggui, JDG) and charred DG are the main processed products of DG, which are used to treat blood stasis syndrome (BSS). However, their therapeutic effect and mechanisms are still unclear. Based on an acute rat BSS model, the intervention effects of DG and its processed products (DGPPs) were evaluated by the hemorheology and coagulation function parameters. Meanwhile, plasma and urine metabolites were detected and analyzed by liquid chromatography coupled to quadrupole time‐of‐flight mass spectrometry and multivariate statistical analysis method. The results of hemorheology, coagulation function parameters and metabolomics all showed that the BSS model was successfully established, DGPPs intervention could significantly relieve rats BSS and the therapeutic effect of JDG was best. Moreover, 23 differential metabolites (14 in plasma and nine in urine) were identified that were closely related to the BSS, involving seven potential target metabolic pathways. DGPP intervention showed different degrees of reverse effect on these metabolites. JDG was the most effective owing to extensive regulation effect on differential metabolites. This study provides a reference for understanding the pathological mechanism of BSS and the mechanism of DGPPs, which lays a theoretical foundation for the rational use of DGPPs in clinical practice.     

Simultaneous quantitation of 23 bioactive compounds in Tanreqing capsule by high‐performance liquid chromatography electrospray ionization tandem mass spectrometry

Tanreqing capsule (TRQC) is a formulation frequently used in traditional Chinese medicine to treat pyrexia, cough, expectoration and pharyngalgia. Since the pharmacological action of traditional Chinese medicines is closely related to their complex and diverse constituents, understanding the exact composition of TRQC is important to elucidate its clinical effectiveness and mechanism of action as well as to establish quality control methods and resolve safety issues. Herein, we employed high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry for the simultaneous quantitation of 23 bioactive compounds in five batches of TRQC; the analytes could be categorized into five types: organic acids (seven compounds), flavonoids (10 compounds), iridoids (two compounds), phenylethanoid glycosides (two compounds) and bile acids (two compounds). The calibration curves for all analytes showed good linearity (r > 0.9953), and the inter‐ and intra‐day precisions did not exceed 4.94 and 4.97%, respectively. The recoveries varied from 90.47% to 109.80%; the corresponding relative standard deviations (RSDs) did not exceed 4.94%; and the repeatability (RSD < 4.72%) and stability (RSD < 4.88%) were also within acceptable limits. Thus, this study can be viewed as a fundamental reference for setting comprehensive TRQC quality standards.     

Pharmacokinetics of salvianolic acid B,rosmarinic acid and Danshensu in rat after pulmonary administration of Salvia miltiorrhiza polyphenolic acid solution

A sensitive and accurate LC–MS/MS method was established for quantifying salvianolic acid B (Sal B), rosmarinic acid (Ros A) and Danshensu (DA) in rat plasma. Salvia miltiorrhiza polyphenolic acid (SMPA), active water‐soluble ingredients isolated and purified from Salvia miltiorrhiza Bge included Sal B, Ros A and DA. The pharmacokinetic analysis of Sal B, Ros A and DA after pulmonary administration of SMPA solution to rat was performed by LC–MS/MS. Results from the pharmacokinetic studies showed that the peak concentration of DA was 21.85 ± 6.43 and 65.39 ± 3.83 ng/mL after pulmonary and intravenous administration, respectively. DA was not detected at 2 h after administration. The absolute bioavailabilities of Sal B and Ros A were respectively 50.37 ± 27.04 and 89.63 ± 12.16% after pulmonary administration of 10 mg/kg SMPA solution in rats. The absolute bioavailability of Sal B increased at least 10‐fold after pulmonary administration, compared with oral administration. It was concluded that the newly established LC–MS/MS method was suitable for describing the pharmacokinetic characteristics of Sal B, Ros A and DA in rat after pulmonary administration of SMPA solution. The data from this study will provide a preclinical insight into the feasibility of pulmonary administration of SMPA.     

Dinuclear cobalt and nickel complexes of a mercaptoacetic acid substituted 1,2,4‐triazole ligand: syntheses,structures and urease inhibitory studies

Because of its versatile coordination modes and strong coordination ability, the mercaptoacetic acid substituted 1,2,4‐triazole 2‐{[5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐3‐yl]sulfanyl}acetic acid ( H₂L ) was synthesized and characterized. Treatment of H₂L with cobalt and nickel acetate afforded the dinuclear complexes {μ‐3‐[(carboxylatomethyl)sulfanyl]‐5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐4‐ido‐κ²N¹,N⁵:N²,O}bis[aqua(methanol‐κO)cobalt(II)] methanol disolvate, [Co₂(C₉H₆N₄O₂S)₂(CH₃OH)₂(H₂O)₂]·2CH₃OH ( 1 ), and {μ‐3‐[(carboxylatomethyl)sulfanyl]‐5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐4‐ido‐κ²N¹,N⁵:N²,O}bis[diaquanickel(II)] methanol disolvate dihydrate, [Ni₂(C₉H₆N₄O₂S)₂(H₂O)₄]·2CH₃OH·2H₂O ( 2 ), respectively. Complex 1 crystallized in the monoclinic space group P2₁/c, while 2 crystallized in the tetragonal space group I4₁/a. Single‐crystal X‐ray diffraction studies revealed that H₂L is doubly deprotonated and acts as a tetradentate bridging ligand in complexes 1 and 2 . For both of the obtained complexes, extensive hydrogen‐bond interactions contribute to the formation of their three‐dimensional supermolecular structures. Hirshfeld surface analysis was used to illustrate the intermolecular interactions. Additionally, the urease inhibitory activities of 1 , 2 and H₂L were investigated against jack bean urease, where the two complexes revealed strong urease inhibition activities.